Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-008225
Filing Date
2022-05-11
Accepted
2022-05-11 07:16:40
Documents
66
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q trvn-20220331x10q.htm   iXBRL 10-Q 1090566
2 EX-10.1 trvn-20220331xex10d1.htm EX-10.1 745375
3 EX-10.2 trvn-20220331xex10d2.htm EX-10.2 221732
4 EX-10.3 trvn-20220331xex10d3.htm EX-10.3 272785
5 EX-31.1 trvn-20220331xex31d1.htm EX-31.1 16916
6 EX-31.2 trvn-20220331xex31d2.htm EX-31.2 16046
7 EX-32.1 trvn-20220331xex32d1.htm EX-32.1 8911
8 EX-32.2 trvn-20220331xex32d2.htm EX-32.2 9255
9 GRAPHIC trvn-20220331xex10d2001.jpg GRAPHIC 14307
  Complete submission text file 0001558370-22-008225.txt   7202803

Data Files

Seq Description Document Type Size
10 EX-101.SCH trvn-20220331.xsd EX-101.SCH 45019
11 EX-101.CAL trvn-20220331_cal.xml EX-101.CAL 44158
12 EX-101.DEF trvn-20220331_def.xml EX-101.DEF 190701
13 EX-101.LAB trvn-20220331_lab.xml EX-101.LAB 416606
14 EX-101.PRE trvn-20220331_pre.xml EX-101.PRE 312675
60 EXTRACTED XBRL INSTANCE DOCUMENT trvn-20220331x10q_htm.xml XML 1038249
Mailing Address 955 CHESTERBROOK BOULEVARD SUITE 110 CHESTERBROOK PA 19087
Business Address 955 CHESTERBROOK BOULEVARD SUITE 110 CHESTERBROOK PA 19087 6103548840
TREVENA INC (Filer) CIK: 0001429560 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36193 | Film No.: 22912061
SIC: 2834 Pharmaceutical Preparations